Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Di Yi Jun Yi Da Xue Xue Bao ; 22(5): 453-5, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12390715

RESUMO

OBJECTIVE: To evaluate the effect of patient-controlled epidural analgesia (PCEA) with ropivacaine or bupivacaine in relieving pain after thymectomy in patients with myasthenia gravis. METHODS: Twenty adult ASA I-II patients with myasthenia gravis were randomized to receive either 0.125% ropivacaine (Group R, n=10) or 0.125% bupivacaine (Group B, n=10) with a PCEA device after transsternal thymectomy. PCEA (continuous infusion at 1 ml/h, bolus dose of 4 ml and lockout time of 30 min) was implemented via an epidural catheter inserted in the T3-4 intervertebral space. The vital signs and visual analogue scale (VAS), together with cumulative consumption (CC) of ropivacaine or bupivacaine were recorded within 48 h postoperatively. RESULTS: The vital signs, including systolic and diastolic blood pressure, heart rate, SpO2, pH and PaCO2, did not show any significant differences between the 2 groups. The CC of the local anesthetic was significantly higher in group R than that in group B at 24 and 48 h postoperatively, but VAS were not significantly different between the 2 groups which was less than 4 in both groups. CONCLUSIONS: PCEA with low concentration of ropivacaine or bupivacaine may provide effective and safe analgesia after transsternal thymectomy.


Assuntos
Analgesia Epidural/métodos , Miastenia Gravis/cirurgia , Dor/prevenção & controle , Timectomia , Adulto , Amidas/uso terapêutico , Anestésicos Locais/uso terapêutico , Pressão Sanguínea/fisiologia , Bupivacaína/uso terapêutico , Dióxido de Carbono/sangue , Feminino , Frequência Cardíaca/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Miastenia Gravis/fisiopatologia , Oxigênio/sangue , Pressão , Ropivacaina , Resultado do Tratamento
2.
Nan Fang Yi Ke Da Xue Xue Bao ; 29(6): 1255-6, 2009 Jun.
Artigo em Zh | MEDLINE | ID: mdl-19726379

RESUMO

OBJECTIVE: To observe the preemptive analgesic effect of flurbiprofen axetil for post-operative pain relief. METHODS: Sixty ASA class I or II patients undergoing postburn plastic surgery were randomly assigned into two groups to receive intravenous administration of 100 mg flurbiprofen axetil (group F, n=30) and 10 ml intravenous saline (group C, n=30) 30 min before surgery. After the operation, all the patients received patient-controlled intravenous analgesia (PCIA) with tramadol for pain relief. The postoperative analgesic effect was assessed by visual analog scales (VAS) at 1, 2, 4, 8, 12 and 24 h after surgery, with tramadol requirements and the adverse effects were recorded. RESULT: At 1, 2, 4, and 8 h after the operation, the patients in group F showed significantly lowered VAS scores as compared with the patients in group C (P<0.05). The requirement of tramadol was also significantly less in group F than in group C (182.9-/+37.4 vs 227.3-/+49.8 mg, P<0.05). No significant difference was found in the adverse effects between the two groups. CONCLUSION: Flurbiprofen axetil can produce preemptive analgesia and reduce the tramadol dose during postoperative PCIA in patients undergoing postburn plastic operations.


Assuntos
Queimaduras/cirurgia , Flurbiprofeno/análogos & derivados , Dor Pós-Operatória/prevenção & controle , Cirurgia Plástica , Tramadol/uso terapêutico , Adulto , Analgesia Controlada pelo Paciente/métodos , Analgésicos Opioides/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Feminino , Flurbiprofeno/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA